Zuclopenthixol
98%
- Product Code: 124925
CAS:
53772-83-1
| Molecular Weight: | 400.9647 g./mol | Molecular Formula: | C₂₂H₂₅ClN₂OS |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 577.4℃ at 760 mmHg | |
| Density: | 1.289g/ml | Storage Condition: | -20℃ |
Product Description:
Zuclopenthixol is primarily used in the treatment of psychiatric disorders, particularly schizophrenia and other psychotic conditions. It helps manage symptoms such as hallucinations, delusions, and disorganized thinking by acting as an antipsychotic agent. It is also effective in controlling aggressive or agitated behavior in patients with severe mental health issues. Additionally, zuclopenthixol is sometimes prescribed for the management of acute manic episodes in bipolar disorder. Its long-acting formulation, zuclopenthixol decanoate, is often used for maintenance therapy to prevent relapse in patients with chronic psychotic disorders, ensuring consistent therapeutic effects over time.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Light Yellow To Yellow Solid |
| Purity (%) | 97.5-100 |
| 1 H Nmr Spectrum | Consistent With Structure |
| Infrared Spectrum | Conforms To Structure |
| Lcms | Consistent With Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿1,580.00 |
+
-
|
| 0.050 | 10-20 days | ฿4,560.00 |
+
-
|
Zuclopenthixol
Zuclopenthixol is primarily used in the treatment of psychiatric disorders, particularly schizophrenia and other psychotic conditions. It helps manage symptoms such as hallucinations, delusions, and disorganized thinking by acting as an antipsychotic agent. It is also effective in controlling aggressive or agitated behavior in patients with severe mental health issues. Additionally, zuclopenthixol is sometimes prescribed for the management of acute manic episodes in bipolar disorder. Its long-acting formulation, zuclopenthixol decanoate, is often used for maintenance therapy to prevent relapse in patients with chronic psychotic disorders, ensuring consistent therapeutic effects over time.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :